Correlation Engine 2.0
Clear Search sequence regions

  • adult (1)
  • allele (4)
  • carrier (4)
  • cross over studies (1)
  • diuresis (2)
  • ENaC (4)
  • family (4)
  • humans (2)
  • loop diuretics (1)
  • male (1)
  • NCC (5)
  • nephron (1)
  • NKCC2 (5)
  • potassium (4)
  • protein human (2)
  • receptors drug (2)
  • rs5723 (1)
  • rs5729 (1)
  • SCNN1A (1)
  • SCNN1B (2)
  • slc12a3 protein, human (1)
  • sodium (3)
  • Sodium Channels (2)
  • subunits (1)
  • thiazides (2)
  • Sizes of these terms reflect their relevance to your search.

    There is little data on genetic predictors of loop diuretic efficacy in humans. Therefore, we investigated the diuretic effects of single oral doses of bumetanide, frusemide, and torsemide in a crossover study in 97 healthy Caucasians in relation to genetic variation in the renal sodium transporters NKCC2 (coded by SLC12A1), NCC (SLC12A3), and ENaC (three subunits coded by SCNN1A, SCNN1B, and SCNN1G). The NCC alanine 264 allele (Gly264Ala) and the most frequent SCNN1B haplotype were associated with stronger diuresis, indicating lower reabsorbing function of these alleles. The variant alleles of the tightly coupled polymorphisms rs5723 (Leu649Leu) and rs5729 in SCNN1G were associated with weaker diuresis, indicating higher activity. Extended haplotype homozygosity implied evolutionary selection of the NCC alanine 264 allele. In conclusion, acute diuretic effects of loop diuretics were affected by genetic variation in sodium transporters that, in the nephron, are located distally from NKCC2.


    S V Vormfelde, D Sehrt, M R Toliat, M Schirmer, I Meineke, M Tzvetkov, P Nürnberg, J Brockmöller. Genetic variation in the renal sodium transporters NKCC2, NCC, and ENaC in relation to the effects of loop diuretic drugs. Clinical pharmacology and therapeutics. 2007 Sep;82(3):300-9

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 17460608

    View Full Text